Bilun Ke

Statistics

Publications

Citations

373

H-Index

Active since

2014

Affiliations

Third Affiliated Hospital of Sun Yat-sen University(Current)

Sun Yat-sen University

Pennington Biomedical Research Center

Louisiana State University System

Key Laboratory of Guangdong Province

Bilun Ke is an author at Third Affiliated Hospital of Sun Yat-sen University specializing in life sciences, cell signaling, and hepatic pathophysiology.

Publications per year

2014–2020

Publications

Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway

Bilun Ke, Zhiyun Zhao, Xin Ye et al. · Diabetes · 2015 · 111 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling

Yidong Yang, Yunwei Guo, Siwei Tan et al. · Nature Communications · 2015 · 86 citations · Full text

Medicine, Cancer Biology, Oncology +16

Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice

Xiuqing Wei, Bilun Ke, Zhiyun Zhao et al. · PLoS ONE · 2014 · 63 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

NF- B/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis

Yunwei Guo, Xiaoying Zhang, Zhiyun Zhao et al. · Acta Pharmaceutica Sinica B · 2020 · 44 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

The peripheral <scp>CB<sub>1</sub> receptor</scp> antagonist <scp>JD5037</scp> attenuates liver fibrosis via a <scp>CB<sub>1</sub> receptor</scp>/β‐arrestin1/<scp>Akt</scp> pathway

Siwei Tan, Huiling Liu, Bilun Ke et al. · British Journal of Pharmacology · 2020 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–5 of 7